1051P Intratumoral injection of LTX-315 in combination with pembrolizumab in patients with advanced melanoma refractory to prior PD-1/PD-L1 therapy: Interim results from the ATLAS-IT-05 trial

Autor: Dalle, S., Marron, T.U., Robert, C., Aljabri, B., Nyakas, M.S., Bruins Slot, K., Sundvold, V., Rekdal, Ø., Sveinbjornsson, B., Currie, G.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S636-S636
Databáze: ScienceDirect